Eradication of a disease: how we cured asymptomatic prostate cancer
- 1 May 2000
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 1, 17-19
- https://doi.org/10.1016/s1470-2045(09)70279-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Asymptomatic Incidence and Duration of Prostate CancerAmerican Journal of Epidemiology, 1998
- Prostate cancer incidence and mortality in the United States and the United Kingdom.JNCI Journal of the National Cancer Institute, 1998
- Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.Journal of Clinical Oncology, 1998
- PSAdynia and other PSA-related syndromes: A new epidemic—A case history and taxonomyUrology, 1997
- Rate of relapse following treatment for localized prostate cancer: A critical analysis of retrospective reportsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implicationsCancer, 1993
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- Evaluation of prostate-specific antigen and prosttic acid phosphatase as prostate cancer markersUrology, 1986
- Immunoperoxidase localization of prostate-specific antigenThe American Journal of Surgical Pathology, 1982
- Geographic pathology of latent prostatic carcinomaInternational Journal of Cancer, 1982